Cargando…

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies

BACKGROUND: In patients with primary hyperoxaluria (PH), endogenous oxalate overproduction increases urinary oxalate excretion, leading to compromised kidney function and often kidney failure. Highly elevated plasma oxalate (Pox) is associated with systemic oxalate deposition in patients with PH and...

Descripción completa

Detalles Bibliográficos
Autores principales: Milliner, Dawn S., Cochat, Pierre, Hulton, Sally-Anne, Harambat, Jerome, Banos, Ana, Dehmel, Bastian, Lindner, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172484/
https://www.ncbi.nlm.nih.gov/pubmed/33515281
http://dx.doi.org/10.1007/s00467-020-04894-9
_version_ 1783702539335630848
author Milliner, Dawn S.
Cochat, Pierre
Hulton, Sally-Anne
Harambat, Jerome
Banos, Ana
Dehmel, Bastian
Lindner, Elisabeth
author_facet Milliner, Dawn S.
Cochat, Pierre
Hulton, Sally-Anne
Harambat, Jerome
Banos, Ana
Dehmel, Bastian
Lindner, Elisabeth
author_sort Milliner, Dawn S.
collection PubMed
description BACKGROUND: In patients with primary hyperoxaluria (PH), endogenous oxalate overproduction increases urinary oxalate excretion, leading to compromised kidney function and often kidney failure. Highly elevated plasma oxalate (Pox) is associated with systemic oxalate deposition in patients with PH and severe chronic kidney disease (CKD). The relationship between Pox and estimated glomerular filtration rate (eGFR) in patients with preserved kidney function, however, is not well established. Our analysis aimed to investigate a potential correlation between these parameters in PH patients from three randomized, placebo-controlled trials (studies OC3-DB-01, OC3-DB-02, and OC5-DB-01). METHODS: Baseline data from patients with a PH diagnosis (type 1, 2, or 3) and eGFR > 40 mL/min/1.73 m(2) were analyzed for a correlation between eGFR and Pox using Spearman’s rank and Pearson’s correlation coefficients. Data were analyzed by individual study and additionally were pooled for Studies OC3-DB-02 and OC5-DB-01 in which the same Pox assay was used. RESULTS: A total of 106 patients were analyzed. A statistically significant inverse Spearman’s correlation between eGFR and Pox was observed across all analyses; correlation coefficients were − 0.44 in study OC3-DB-01, − 0.55 in study OC3-DB-02, − 0.51 in study OC5-DB-01, and − 0.49 in the pooled studies (p < 0.0064). CONCLUSIONS: Baseline evaluations showed a moderate and statistically significant inverse correlation between eGFR and Pox in patients with PH already at early stages of CKD (stages 1–3b), demonstrating that a correlation is present before substantial loss in kidney function occurs. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-020-04894-9.
format Online
Article
Text
id pubmed-8172484
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81724842021-06-07 Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies Milliner, Dawn S. Cochat, Pierre Hulton, Sally-Anne Harambat, Jerome Banos, Ana Dehmel, Bastian Lindner, Elisabeth Pediatr Nephrol Original Article BACKGROUND: In patients with primary hyperoxaluria (PH), endogenous oxalate overproduction increases urinary oxalate excretion, leading to compromised kidney function and often kidney failure. Highly elevated plasma oxalate (Pox) is associated with systemic oxalate deposition in patients with PH and severe chronic kidney disease (CKD). The relationship between Pox and estimated glomerular filtration rate (eGFR) in patients with preserved kidney function, however, is not well established. Our analysis aimed to investigate a potential correlation between these parameters in PH patients from three randomized, placebo-controlled trials (studies OC3-DB-01, OC3-DB-02, and OC5-DB-01). METHODS: Baseline data from patients with a PH diagnosis (type 1, 2, or 3) and eGFR > 40 mL/min/1.73 m(2) were analyzed for a correlation between eGFR and Pox using Spearman’s rank and Pearson’s correlation coefficients. Data were analyzed by individual study and additionally were pooled for Studies OC3-DB-02 and OC5-DB-01 in which the same Pox assay was used. RESULTS: A total of 106 patients were analyzed. A statistically significant inverse Spearman’s correlation between eGFR and Pox was observed across all analyses; correlation coefficients were − 0.44 in study OC3-DB-01, − 0.55 in study OC3-DB-02, − 0.51 in study OC5-DB-01, and − 0.49 in the pooled studies (p < 0.0064). CONCLUSIONS: Baseline evaluations showed a moderate and statistically significant inverse correlation between eGFR and Pox in patients with PH already at early stages of CKD (stages 1–3b), demonstrating that a correlation is present before substantial loss in kidney function occurs. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-020-04894-9. Springer Berlin Heidelberg 2021-01-30 2021 /pmc/articles/PMC8172484/ /pubmed/33515281 http://dx.doi.org/10.1007/s00467-020-04894-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Milliner, Dawn S.
Cochat, Pierre
Hulton, Sally-Anne
Harambat, Jerome
Banos, Ana
Dehmel, Bastian
Lindner, Elisabeth
Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
title Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
title_full Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
title_fullStr Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
title_full_unstemmed Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
title_short Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
title_sort plasma oxalate and egfr are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172484/
https://www.ncbi.nlm.nih.gov/pubmed/33515281
http://dx.doi.org/10.1007/s00467-020-04894-9
work_keys_str_mv AT millinerdawns plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies
AT cochatpierre plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies
AT hultonsallyanne plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies
AT harambatjerome plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies
AT banosana plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies
AT dehmelbastian plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies
AT lindnerelisabeth plasmaoxalateandegfrarecorrelatedinprimaryhyperoxaluriapatientswithmaintainedkidneyfunctiondatafromthreeplacebocontrolledstudies